Cambium Bio Ltd (CMB) — Cash Flow Quality Index
Cambium Bio Ltd (CMB) has a Cash Flow Quality Index of -0.82x as of March 2023. Operating cash flow of AU$-308.70K is below net income of AU$374.44K, suggesting accrual-heavy earnings not yet converted to cash. Explore CMB cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cambium Bio Ltd Cash Flow Quality Index (1999–2021)
Historical Cash Flow Quality Index for Cambium Bio Ltd across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check CMB cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Cambium Bio Ltd (1999–2021)
Year-by-year earnings quality comparison for Cambium Bio Ltd. For live market cap and the full company financial profile, see Cambium Bio Ltd market cap and net worth.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 0.88x | AU$2.42 Million | AU$2.76 Million | ▼ -20.1% |
| 2017 | 1.10x | AU$3.59 Million | AU$3.27 Million | ▼ -41.5% |
| 2001 | 1.88x | AU$38.20 Million | AU$20.36 Million | ▲ +6.6% |
| 2000 | 1.76x | AU$48.26 Million | AU$27.42 Million | ▼ -20.8% |
| 1999 | 2.22x | AU$33.43 Million | AU$15.03 Million | — |